[HTML][HTML] Apoe4 and Alzheimer's disease pathogenesis—Mitochondrial deregulation and targeted therapeutic strategies

M Pires, AC Rego - International Journal of Molecular Sciences, 2023 - mdpi.com
APOE ε4 allele (ApoE4) is the primary genetic risk factor for sporadic Alzheimer's disease
(AD), expressed in 40–65% of all AD patients. ApoE4 has been associated to many …

[HTML][HTML] REST and neural gene network dysregulation in iPSC models of Alzheimer's disease

K Meyer, HM Feldman, T Lu, D Drake, ET Lim, KH Ling… - Cell reports, 2019 - cell.com
The molecular basis of the earliest neuronal changes that lead to Alzheimer's disease (AD)
is unclear. Here, we analyze neural cells derived from sporadic AD (SAD), APOE4 gene …

The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons

CR Muratore, HC Rice, P Srikanth… - Human molecular …, 2014 - academic.oup.com
Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by
extracellular plaques containing amyloid β (Aβ)-protein and intracellular tangles containing …

iPS cells: a game changer for future medicine

H Inoue, N Nagata, H Kurokawa, S Yamanaka - The EMBO journal, 2014 - embopress.org
The induced pluripotent stem cell (i PSC) technology is instrumental in advancing the fields
of disease modeling and cell transplantation. We herein discuss the various issues …

The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis

K Imamura, Y Izumi, A Watanabe, K Tsukita… - Science Translational …, 2017 - science.org
Amyotrophic lateral sclerosis (ALS), a fatal disease causing progressive loss of motor
neurons, still has no effective treatment. We developed a phenotypic screen to repurpose …

[HTML][HTML] Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease

R Balez, N Steiner, M Engel, SS Muñoz, JS Lum… - Scientific reports, 2016 - nature.com
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases, yet
current therapeutic treatments are inadequate due to a complex disease pathogenesis. The …

[HTML][HTML] Functionalization of brain region-specific spheroids with isogenic microglia-like cells

L Song, X Yuan, Z Jones, C Vied, Y Miao, M Marzano… - Scientific reports, 2019 - nature.com
Current brain spheroids or organoids derived from human induced pluripotent stem cells
(hiPSCs) still lack a microglia component, the resident immune cells in the brain. The …

[HTML][HTML] Cellular functions of the amyloid precursor protein from development to dementia

R Van Der Kant, LSB Goldstein - Developmental cell, 2015 - cell.com
Amyloid precursor protein (APP) is a key player in Alzheimer's disease (AD). The Aβ
fragments of APP are the major constituent of AD-associated amyloid plaques, and …

Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer's Disease

MS Uddin, D Tewari, G Sharma, MT Kabir… - Molecular …, 2020 - Springer
Alzheimer's disease (AD) is a progressive neurodegenerative disease involving aggregation
of misfolded proteins inside the neuron causing prolonged cellular stress. The …

Hallmarks of Alzheimer's disease in stem-cell-derived human neurons transplanted into mouse brain

I Espuny-Camacho, AM Arranz, M Fiers, A Snellinx… - Neuron, 2017 - cell.com
Human pluripotent stem cells (PSCs) provide a unique entry to study species-specific
aspects of human disorders such as Alzheimer's disease (AD). However, in vitro culture of …